Some people play Monopoly for fun. Sam Altman plays it with your central nervous system as collateral. Listen up, because this isn’t some half-baked AI doodad or another app that finds your soulmate by swiping right on your neuroses—no, this is Wall Street meets Westworld, and the buy-in is your prefrontal cortex. OpenAI, flush with enough capital to buy Pluto and mineral rights to your immortal soul, just cut a check for Merge Labs, Altman’s brain-wrangling brainchild. Do you crave synergy? Merge Labs is building tech to get you so synergized with your computer that you and your email client can finally settle your differences—by mind-melding. Forget market data; Merge wants the market’s *collective unconscious* on the balance sheet. Altman, who apparently owns every fourth neuron in Silicon Valley, has assembled a team so smart you’d need a quantum abacus to count their IQs. They’ve already hoovered up a quarter of a billion in funding from OpenAI, venture boys, and even Gabe Newell, who clearly wants Half-Life to launch directly into your cerebral cortex. Why waste time inputting commands with your clumsy meat-hands when you can just think, ‘Pump the stock,’ and suddenly Tesla is up 6% on pure willpower? “But Gordon,” you might say, “isn’t this just that musk-eteering Neuralink jazz?” Oh, amateur hour. Neuralink wants to put chips *inside* your brain, like it’s stuffing a foie gras duck. Merge? Too classy for that kind of incision. They’re waving ultrasounds and molecular voodoo over your temples till your neurons tap-dance out Morse code. No drilling. No scars. You’ll show up at the board meeting unfazed, unless you accidentally broadcast your lunchtime thoughts to the projections spreadsheet. Hope you like tuna. AI comes in, smirking, says it’s going to interpret your intent—because bro, you can’t even interpret your own. Think of it as Clippy with a PhD in neurobiology and a taste for leveraged buyouts. High bandwidth intent-tracking. AI that’s more attentive to your moods than your third ex-wife. If you feel uneasy, don’t worry: the AI can’t read your poker face if you never learned how to bluff. Competitors? Sure, there are a few. Synchron is elbow-deep in brain chips, Nvidia’s sniffing around, but let me be clear: this is the dawn of hostile takeovers of your subconscious. Forest Neurotech, Merge’s nonprofit cousin, is apparently still out in the wilds tranquilizing whatever’s left of your brain that hasn’t been monetized. They’re doing ultrasound trials in Blighty, which is British for ‘where the real cash comes from’ on the secondary market. So what’s next? Merge hasn’t told anyone what exactly they’ll do with their squishy new data feed, but will it cure mental health? Will it fire your synapses faster than cocaine off a mahogany desk? Or will it streamline the greatest achievement of the American Dream: trading fast, living faster, outlasting your own humanity by merging with your own portfolio? If you want in, they’re hiring. But don’t show up with a resume—show up with neurons ready to be IPO’d. The future is now, and it’s about time your corpus callosum started pulling its financial weight.